v3.25.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Balance at Dec. 31, 2023 $ 585,410 $ 1,179 $ 771,336 $ (200,319) $ 12,544 $ 670
Balance, shares at Dec. 31, 2023   117,857,055        
Net income (loss) [1] (34,530)     (34,061)   (469)
Other comprehensive income (loss), net of tax (13,249)       (13,249)  
Share-based compensation 55,194   55,194      
Shares issued under share-based compensation plan, including tax effects 531 $ 3 528      
Shares issued under share-based compensation plan, including tax effects, shares   318,085        
Shares issued for payment of acquisition 31,081 $ 26 31,055      
Shares issued for payment of acquisition, shares   2,570,503        
Derecognition of redeemable noncontrolling interest 12,439   12,439      
Issuance of common stock on initial public offering, net [2] 656,485 $ 533 655,952      
Issuance of common stock on initial public offering, net, shares [2]   53,333,334        
Proceeds from stock purchase contract issued under tangible equity units, net [3] 321,611   321,611      
Balance at Sep. 30, 2024 1,614,972 $ 1,741 1,848,115 (234,380) (705) 201
Balance, shares at Sep. 30, 2024   174,078,977        
Balance at Jun. 30, 2024 1,599,933 $ 1,714 1,804,965 (226,150) 19,025 379
Balance, shares at Jun. 30, 2024   171,397,030        
Net income (loss) [4] (8,408)     (8,230)   (178)
Other comprehensive income (loss), net of tax (19,730)       (19,730)  
Share-based compensation 15,210   15,210      
Shares issued under share-based compensation plan, including tax effects 509 $ 2 507      
Shares issued under share-based compensation plan, including tax effects, shares   210,696        
Shares issued for payment of acquisition 30,000 $ 25 29,975      
Shares issued for payment of acquisition, shares   2,471,251        
Derecognition of redeemable noncontrolling interest (2,542)   (2,542)      
Balance at Sep. 30, 2024 1,614,972 $ 1,741 1,848,115 (234,380) (705) 201
Balance, shares at Sep. 30, 2024   174,078,977        
Balance at Dec. 31, 2024 1,647,855 $ 1,742 1,866,850 (222,155) 1,418  
Balance, shares at Dec. 31, 2024   174,245,990        
Net income (loss) [1] 113,680     113,586   94
Other comprehensive income (loss), net of tax (7,709)       (7,709)  
Share-based compensation 55,733   55,733      
Exercise of stock options 14,681 $ 21 14,660      
Exercise of stock options, shares   2,055,618        
Issuance of common stock for settlement of RSUs   $ 18 (18)      
Issuance of common stock for settlement of RSUs, shares   1,817,356        
Tax effect of net share settlement of equity awards (5,583) $ (2) (5,581)      
Tax effect of net share settlement of equity awards, shares   (264,547)        
Conversion of tangible equity units into common stock   $ 28 (28)      
Conversion of tangible equity units into common stock, shares   2,831,467        
Balance at Sep. 30, 2025 1,818,657 $ 1,807 1,931,616 (108,569) (6,291) 94
Balance, shares at Sep. 30, 2025   180,685,884        
Balance at Jun. 30, 2025 1,742,607 $ 1,771 1,909,854 (164,405) (4,330) (283)
Balance, shares at Jun. 30, 2025   177,055,327        
Net income (loss) [4] 56,213     55,836   377
Other comprehensive income (loss), net of tax (1,961)       (1,961)  
Share-based compensation 17,250   17,250      
Exercise of stock options 5,619 $ 7 5,612      
Exercise of stock options, shares   735,483        
Issuance of common stock for settlement of RSUs   $ 1 (1)      
Issuance of common stock for settlement of RSUs, shares   115,810        
Tax effect of net share settlement of equity awards (1,071)   (1,071)      
Tax effect of net share settlement of equity awards, shares   (52,203)        
Conversion of tangible equity units into common stock   $ 28 (28)      
Conversion of tangible equity units into common stock, shares   2,831,467        
Balance at Sep. 30, 2025 $ 1,818,657 $ 1,807 $ 1,931,616 $ (108,569) $ (6,291) $ 94
Balance, shares at Sep. 30, 2025   180,685,884        
[1]

(1) Net income (loss) to the Company for the nine months ended September 30, 2025 and 2024 excludes $(1,370) and $(1,395), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[2]

(2) Issuance of common stock on initial public offering is presented net of underwriting discounts and commissions, and offering-related expenses of $36.8 million.
[3]

(3) Proceeds from stock purchase contract issued under tangible equity units is presented net of underwriting discounts and commissions of $9.1 million.
[4]

(1) Net income (loss) to the Company for the three months ended September 30, 2025 and 2024 excludes $(455) and $(573), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.